Senior NHS England clinician Celia Ingham Clark has been appointed as interim national patient safety director for England.
This new role will effectively be a joint appointments across both NHS in England and NHS Improvement, providing Clark with a joined-up and collaborative role.
The eminent professional previously worked as the national director for reducing premature deaths at NHS England.
Clark will replace Mike Durkin, who had stepped down after five years in the job at the end of May.
The role will initially be taken on for a six-month period, with Clark also continuing in the existing position at NHS England, as the medical director for clinical effectiveness.
Clark had worked as a consultant general surgeon before becoming medical director at the Whittington Hospital Trust.
She had continued in this position for eight years, building up a significant amount of clinical experience in this time.
Aside from this, Clark also served as associate medical director with responsibility for quality at NHS London.
While another significant position held by Clark was that of chair of the cross-system sepsis board.
Kathy Mclean, executive medical director at NHS Improvement, was very positive about this new appointment.
“We are very pleased to welcome Celia Ingham Clark as interim NHS national director of patient safety. Celia will continue her current role as NHS England’s medical director for clinical effectiveness, and I’m sure this will help us to further join and boost our efforts with NHS England to help improve NHS care.”
McLean went on to outline the particular qualities that Clark will bring to the role.
“Celia brings a wealth of knowledge and experience to her new role – including significant experience at a trust and with programmes to reduce premature mortality and sepsis. I’m sure Celia’s appointment will strengthen our efforts to help trusts improve patient safety and build on the work we are doing to embed an open and learning culture across the NHS.”